World’s largest sovereign wealth fund posts $138 billion in H1 profit

The Norges Bank, Norway's central bank, in Oslo, Norway, on Tuesday, Oct. 17, 2023.Bloomberg | Bloomberg | Getty ImagesNorway's massive sovereign wealth fund on Wednesday posted first-half profit of 1.48 trillion kroner ($138 billion), primarily driven by robust returns on its investments in technology stocks.The so-called Government Pension Fund...

Read more...

Apple supplier Foxconn’s second-quarter profit rises 6% on AI boom

Hon Hai Group's headquarters in Taipei, Taiwan.Ceng Shou Yi | Nurphoto | Getty ImagesApple supplier Foxconn reported on Wednesday a 6% rise in second-quarter net profit, driven by strong AI server demand as the company touted "strong growth momentum" from the technology boom.The Taiwanese company, the world's largest contract electronics maker, said net...

Read more...

UBS second-quarter earnings 2024

General view of the UBS building in Manhattan, New York City, on June 5, 2023.Eduardo Munoz Alvarez | View Press | Corbis News | Getty ImagesSwiss banking giant UBS on Wednesday smashed net profit expectations for the second quarter, as revenue came in higher than expected.Net profit attributable to...

Read more...

Home Depot (HD) Q2 2024 earnings

Home Depot on Tuesday topped quarterly expectations, but cautioned that sales will be weaker than expected in the back half of the year as high interest rates and consumer uncertainty dampen demand.The home improvement retailer said it now expects full-year comparable sales to decline by 3% to 4% compared...

Read more...

Eli Lilly’s blowout quarter should quiet concerns about the stock

Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Revenue in the second quarter jumped 36% year over year to $11.3 billion, easily topping expectations of $9.92 billion, according to estimates compiled...

Read more...

Eli Lilly’s second quarter suggests it’s gaining in weight loss race

Eli Lilly shares are surging after it posted impressive second-quarter results, helped by a combination of more supply and better pricing for its blockbuster weight loss drugs, Mounjaro and Zepbound, suggesting it might be gaining ground against Novo Nordisk . "Investors were nervous going in and this print would...

Read more...